基础医学与临床 ›› 2010, Vol. 30 ›› Issue (12): 1245-1251.

• 研究论文 •    下一篇

脱氧核酶抑制鼻咽癌细胞EBV-LMP1的表达

柯霞,杨玉成,洪苏玲   

  1. 重庆医科大学附属第一医院耳鼻咽喉科
  • 收稿日期:2009-08-24 修回日期:2010-01-18 出版日期:2010-12-05 发布日期:2010-12-05
  • 通讯作者: 洪苏玲

In vivo and in vitro research on inhibiting effects of DNAzyme on EBV-LMP1 of NPC cells

KE Xia ,YANG Yu-cheng ,HONG Su-ling   

  1. Department of Otolaryngology, the First Affiliated Hospital,Chongqing Medical University
  • Received:2009-08-24 Revised:2010-01-18 Online:2010-12-05 Published:2010-12-05
  • Contact: HONG Su-ling

摘要: 目的 探讨l 0- 23脱氧核酶(1 0-23DR z)对鼻咽癌生长的抑制作用。 方法 设计合成针对EBV-LMP1的l0-23DRz,并对其进行硫代磷酸化修饰,同时针对该位点设计突变型DR z和反义寡核苷酸,经脂质体转染C666-1细胞中观察其对LMP1基因表达的抑制效应;建立裸鼠皮下鼻咽癌移植瘤,瘤体内注射脱氧核酶及其类似物,观察其对LMP1基因及肿瘤生长的抑制效应。 结果 有效转染后,脱氧核酶在细胞内抑制LMP1基因表达;成功建立裸鼠移植瘤模型后,脱氧核酶能高效抑制LMP1基因表达,并能抑制肿瘤生长,其作用较突变型脱氧核酶和反义寡核苷酸强(P<0.05)。 结论 脱氧核酶在鼻咽癌细胞中及移植瘤模型中都能高效抑制LMP1的表达,可能成为一种高度特异性的、高效的基因治疗剂。

关键词: 脱氧核酶, LMP1基因, 鼻咽癌, 裸鼠

Abstract: Objective To explore the inhibitting effect of 1 0-23DNAzyme on the growth of nasopharyngeal carcinoma (NPC) cell,EBV-LMP1both in vivo and in vitro.Methods Thosthorothioate 1O- 23DNAzyme and analogs targetted on EBV-LMP1 (Epstein-Barr virus encoded latent membrane protein 1)gene mRNA were designed and synthesized ,and transfected into C666-1 cells with lipofectamine ,observing the inhibiting effect on LMP1 . Xenografts of NPC in nude mice were formed ,and after DNAzyme and analogs were injected in tumor, the depressive effects on the growth of tumor and LMP1 gene were assessed.Results The results showed that DNAzyme inhibited the expression of LMP1 gene in vivo and in vitro ,and also the growth and metastasis of xenograft of NPC were depressed,and it was found that the effect of DNAzyme, was better than that of its analogs. (P〈0.05). Conclusion 10-23DRz can strongly block the expression of EBV-LMP1gene in the C666-1 cell model and xenograft in nude mice .It might serve as a specific and effective anti-LMP1 gene therapeutic candidate agent.